SecBot SecBot

STOK

Stoke Therapeutics, Inc.
Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0001623526 Biotech & Drug Discovery
$26.63 −0.05 (−0.19%)
Nov 16 4:00 PM ET · prev $26.68
Market cap
$1.7B
Small cap
Median target
$43.00
+61% · range $35.00–60.00
1 year
−1.2%
from $26.95 · Nov 17
30 days
+7.3%
from $24.82
52-week range
$22.50–38.35
−31% from high · low Oct 13
Avg volume 20D
1.36M
shares / day
Short interest
10.72M
≈16.4% of shares · +4.5%
Days to cover
6.8
at average volume
Insider net
−$2.5M
0 buyers · 5 sellers · since Mar 18
New fund stakes
0
Q3 2026 13F · 0 exits
Filing reports
18
analyzed by SecBot
SecBot read MIXED 9 reports · 90 days
Balance 1 bearish · 0 bullish · 8 neutral oldest → newest, height = score
Avg score ·High conf. 5/9

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

  • Mar 18 to Mar 20 ▼ 3 days of insider sells: $744.8K by 4 insiders, avg $32.17
  • May 1 ▼ 1 insider sell $73.5K at $32.79
  • Jun 1 ▼ 1 insider sell $54.9K at $30.58
  • Jun 16 ▼ 1 insider sell $43.6K at $29.95
  • Jul 1 ▼ 1 insider sell $236.1K at $32.66
  • Jul 13 Goldman Sachs initiates
  • Aug 3 ▼ 1 insider sell $208.4K at $29.04
  • Aug 18 ▼ 3 insiders sell $646.9K at $32.03
  • Sep 1 ▼ 1 insider sell $170.1K at $30.67
  • Oct 1 to Oct 2 ▼ 2 days of insider sells: $44.0K by 2 insiders, avg $26.22
  • Oct 21 ▼ Director Edward M. Kaye, MD, filed a Form 144 on October 21, 2026, i…
  • Nov 2 ▼ 1 insider sell $189.9K at $26.39

Signal stack

Where each data set points today.

  • InsidersBEARISH

    5 insiders sold $2.5M.

  • InstitutionsMIXED

    Q3 2026: 20 added (0 new), 14 trimmed or exited.

  • EstimatesFALLING

    Current-quarter EPS estimate −$0.973 → −$1.186 over 90 days. 1 up, 2 down in 30 days.

  • Short sellersSTEADY

    Short interest +4.5% to 10.72M shares. 6.8 days to cover, ≈16.4% of shares.

  • TrendUPTREND

    1% above its 50-day average.

  • SocialQUIET

    No Reddit mentions this week. Last mention Oct 29.

Who's buying

13F· Q3 2026
0
new positions
0
exits
FundMoveSharesValue
UBS Group AGADD263,503$6.9M
FRANKLIN TEMPLETON INCADD199,682$5.5M
VICTORY CAPITAL MANAGEMENT INCDOUBLED106,973$2.8M
TD ASSET MANAGEMENT INCADD100,108$2.6M
ALPS ADVISORS INCADD85,483$2.2M
FIRST TRUST ADVISORS LPNEAR_EXIT62,355$1.6M
JANE STREET GROUP, LLCNEAR_EXIT60,556$1.6M
Rafferty Asset Management, LLCADD56,933$1.5M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

Last action Aug 2026
12-month targets · 13 analysts

Price is below the lowest target. Median implies +61%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Aug 4, 2026Guggenheim
REITERATE
REITERATEBuy
Aug 4, 2026Wedbush
MAINTAIN
MAINTAINOutperform
Aug 4, 2026Canaccord Genuity
MAINTAIN
MAINTAINBuy
Aug 4, 2026Chardan Capital
MAINTAIN
MAINTAINBuy
Jul 13, 2026Goldman Sachs
INITIATE
INITIATEBuy

Washington

Corporate Lobbying

7 lobbying filings and 0 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Insider ledger

Form 4
$0
bought · 0 insiders
$2.5M
sold · 5 insiders
DateInsiderTypeValue
Nov 2, 2026
Ticho Barry
CHIEF MEDICAL OFFICER
Nov 2, 2026
SELL$5.4K
Nov 2, 2026
Ticho Barry
CHIEF MEDICAL OFFICER
Nov 2, 2026
SELL$184.5K
Oct 2, 2026
Allan Jonathan
GENERAL COUNSEL & CORP SEC
Oct 2, 2026
SELL$16.5K
Oct 1, 2026
Ticho Barry
CHIEF MEDICAL OFFICER
Oct 1, 2026
SELL$27.5K
Sep 23, 2026
Cumbo Alexander
Director
Sep 23, 2026
AWARD39,674 sh
Sep 1, 2026
Ticho Barry
CHIEF MEDICAL OFFICER
Sep 1, 2026
SELL$49.7K
Sep 1, 2026
Ticho Barry
CHIEF MEDICAL OFFICER
Sep 1, 2026
SELL$120.4K
Aug 18, 2026
Allan Jonathan
GENERAL COUNSEL & CORP SEC
Aug 18, 2026
SELL$86.9K

Earnings setup

Estimates
−$1.19
EPS estimate, this quarter
−22%
estimate change, 90 days
1↑ 2↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$1.19-$1.34–-$1.08-22.2%$7.4M
Next Q🔒 Fresh data, subscribers only
Current FY-$4.01-$4.29–-$3.89-10.8%$34.7M
Next FY🔒 Fresh data, subscribers only
Reddit
Recent posts
All social signals and their track records

Short side

FINRA· Oct 30, 2026
10,722,415
shares short
+4.5%
vs prior settlement
6.8
days to cover
≈16.4%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 2, 2026 Insider
Ticho Barry sold 200 shares
CHIEF MEDICAL OFFICER @ $26.99 ($5.4K)
Nov 2, 2026 Insider
Ticho Barry sold 6,995 shares
CHIEF MEDICAL OFFICER @ $26.38 ($184.5K)
Nov 2, 2026 Earnings calendar
STOK Q3 2026 Earnings Scheduled · 2026-11-02
Oct 2, 2026 Insider
Allan Jonathan sold 627 shares
GENERAL COUNSEL & CORP SEC @ $26.33 ($16.5K)
Sep 30, 2026 Inst.
UBS Group AG · ADD
263,503 shares ($6.9M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

SecBot reports

18 filings · 1 bullish · 4 bearish · 13 neutral
All STOK filing & press-release reports (18)